EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Influenza virus infection affects the efficacy of the treatment of dyslipidemia in mice with a polyisoprenoid-based drug

E A Makiev iD, T N Kozhevnikova iD, A V Pronin iD, A N Narovlyansky iD, A V Sanin iD, I V Ganshina iD, M M Shmarov iD

Problems of Virology · 30.04.2026 · 71 (2) · 139-149

DOI: 10.36233/0507-4088-343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Problems of Virology, online erschienen am 30.04.2026. Verfasst von E A Makiev und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Research Centre for Epidemiology and Microbiology named after the Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russia…. Hauptthemen laut MEDLINE: Dyslipidemias, Orthomyxoviridae Infections, Sitosterols, Polyisoprenyl Phosphates. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate how influenza infection affects the hypolipidemic effect of a novel combined drug – Prenophytol based on polyisoprenoids (sodium polyprenyl phosphate and beta-sitosterol) in mice with experimental dyslipidemia. Materials and methods. In BALB/c mice with experimentally induced dyslipidemia, the impact of Prenophytol on lipid metabolism parameters was assessed. Currently the drug is at the stage of clinical trials (Roszdravnadzor's permission to conduct clinical trials No. 362 dated 08/14/2025). A subset of animals was infected with influenza A/California/07/2009 (H1N1) virus.

Results

Administration of the drug to dyslipidemia mice resulted in a significant reduction in total cholesterol, triglycerides, and LDL levels, along with a significant increase in HDL. However, in the presence of influenza infection, the hypolipidemic effect of Prenophytol was markedly attenuated: only cholesterol levels decreased significantly, whereas changes in triglycerides, LDL, and HDL did not reach statistical significance.

Conclusions

Influenza infection diminishes the therapeutic efficacy of the Prenophytol in the treatment of dyslipidemia. These findings indicate that concomitant viral infections must be taken into account when designing dyslipidemia treatment regimens and conducting clinical trials of this drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DyslipidemiasOrthomyxoviridae InfectionsSitosterolsPolyisoprenyl PhosphatesHypolipidemic AgentsInfluenza, HumanAnimalsMiceInfluenza A Virus, H1N1 SubtypeHumansMice, Inbred BALB CTriglyceridesCholesterolDisease Models, Animal

Stichwörter der Autor:innen

Prenophytolbeta-sitosteroldyslipidemiahypolipidemic therapyinfluenza viruspoloxamer 407polyisoprenoidssodium polyprenyl phosphateviral infection

Substanzen

SitosterolsTriglyceridesgamma-sitosterolCholesterolPolyisoprenyl PhosphatesHypolipidemic Agents

Autor:innen und Institutionen

  • National Research Centre for Epidemiology and Microbiology named after the Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation.

ORCID-Profile: E A Makiev, T N Kozhevnikova, A V Pronin, A N Narovlyansky, A V Sanin, I V Ganshina, M M Shmarov

Zitieren

APA

Makiev, E. A., Kozhevnikova, T. N., Pronin, A. V., Narovlyansky, A. N., Sanin, A. V., Ganshina, I. V., & Shmarov, M. M. (2026). Influenza virus infection affects the efficacy of the treatment of dyslipidemia in mice with a polyisoprenoid-based drug. Problems of Virology, 71(2), 139-149. https://doi.org/10.36233/0507-4088-343

Vancouver

Makiev EA, Kozhevnikova TN, Pronin AV, Narovlyansky AN, Sanin AV, Ganshina IV, et al. Influenza virus infection affects the efficacy of the treatment of dyslipidemia in mice with a polyisoprenoid-based drug. Problems of Virology. 2026;71(2):139-149. doi:10.36233/0507-4088-343

BibTeX
@article{Makiev2026,
  author = {Makiev, E A and Kozhevnikova, T N and Pronin, A V and Narovlyansky, A N and Sanin, A V and Ganshina, I V and Shmarov, M M},
  title = {Influenza virus infection affects the efficacy of the treatment of dyslipidemia in mice with a polyisoprenoid-based drug},
  journal = {Problems of Virology},
  year = {2026},
  volume = {71},
  number = {2},
  pages = {139--149},
  doi = {10.36233/0507-4088-343}
}
Kostenlos starten →